Kallikrein proteolytic cascade plays a crucial role in various skin diseases. A series of coumarinic derivatives were identified with IC50 in the nanomolar range against kallikreins. Identified coumarinic derivatives are devoided of any cellular toxicity and demonstrated potent in vivo proteolysis inhibition